CD79A and infection: This could indicate higher baseline cross-reactivity for beta-HCoV IgA, relative to IgG, and the decrease in IgA cross-reactivity following infection could be due to a relatively higher proportion of SARS-CoV-2-specific S1 (rather than the conserved S2) IgA responses post-SARS-CoV-2 infection.